Covington, Latham Advise on $2.6 Billion Pharma Merger

, The Am Law Daily

   |0 Comments

The Am Law 100 firms are advising on the proposed $2.6 billion sale of specialty pharmaceutical company Santarus and its portfolio of gastrointestinal drugs to Salix Pharmaceuticals.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202626952428

Thank you!

This article's comments will be reviewed.